People with MS had higher blood mercury and chromium
By MS Buddy ·
Summarized from Clinical and translational gastroenterology, Nov 2026 · PubMed · DOI. AI-generated summary. Not medical advice.
Observational study · 305 people with MS, bowel diseases, and healthy volunteers
Research by Samuel Narvey, Charles Bernstein and 5 colleagues at the University of Manitoba in Canada.
How do blood metal levels in people with MS compare with healthy volunteers?
Key Takeaway
People with MS had higher blood levels of mercury and chromium, but lower levels of aluminum and titanium, than healthy volunteers.

What They Found
Researchers compared blood metal levels in people with MS, two bowel diseases, and healthy volunteers. People with MS had higher mercury and chromium levels than healthy volunteers. Their aluminum and titanium levels were lower. Aluminum was higher in Crohn's disease but lower in ulcerative colitis than in healthy volunteers. In a smaller study, blood metal levels did not clearly match levels in intestinal tissue.
Who Should Care and Why
The blood comparison included people with MS, Crohn's disease, ulcerative colitis, and healthy volunteers. It included 49 people with MS. The MS group served as a comparison for the bowel disease groups. The study found differences in blood metal levels, not whether metals cause MS or bowel disease. A separate group undergoing colon exams provided blood and intestinal tissue samples.
Important Considerations
You should know the blood comparison included 287 people, while the separate tissue study included 18. These were comparisons, not tests of a treatment. The findings do not show whether metal exposure caused any of the diseases.
AI-generated summary — for informational purposes only, not medical advice
Read the original abstract
Published in Clinical and translational gastroenterology by et al.. Reproduced from the PubMed record.
Emerging evidence implicates heavy metals (HM) as environmental factors which may influence Crohn's disease (CD) and ulcerative colitis (UC) pathogenesis. The present report includes two related studies. The first ('serum-only') compares HM serum levels (parts per billion, ppb) in people with CD and UC, including aluminum (Al), chromium (Cr), mercury (Hg), and titanium (Ti) compared to people with multiple sclerosis (MS) and healthy controls (HC). The second study correlated serum and tissue levels of HM in 18 persons undergoing colonoscopy and biopsy. Serum and intestinal biopsies of Al, Cr, Ti, and Hg concentrations were quantified using inductively coupled plasma mass spectrometry for both studies. The serum-only study included 287 participants (CD (n=100), UC (n=50), MS (n=49), and HC (n= 88)). Versus HC, adjusted serum Al concentrations were higher in CD [fold change, 1.34; 95%CI (1.12-1.61)], lower in UC [0.64; 95%CI (0.51-0.80)], and lower in MS [0.76; 95%CI (0.60-0.97)]. Ti concentrations were lower in all three disease groups versus HC. Cr concentrations, higher in MS [2.34; 95% CI (1.59-3.45)], did not differ significantly between HC and either CD or UC. Hg concentrations were higher in both CD [2.17; 95%CI (1.52-3.09) and MS [1.62; 95%CI (1.02-2.59)]. In our small exploratory substudy, we found no statistically significant correlation between serum and intestinal tissue HM levels. Our report demonstrates differences in serum HM levels in people with CD relative to persons with UC or HC. Future research will benefit from the evaluation of these disparities and identification of potential implicated mechanisms.
Categories
Explore more research
Related MS research

11/19/2026
A review of 50 studies found wide differences in MS rates across the Americas. MS became more common
Read More
11/20/2026
A study of online MS medication discussions found two main styles: sharing personal experiences and
Read More
11/18/2026
A review finds limited direct evidence that diet, exercise, or gut microbes affect MS through the bo
Read More
11/19/2026
Interviews with 17 people newly diagnosed with relapsing-remitting MS explored fear, doubt, and unce
Read More
11/18/2026
This review explores how pregnancy may affect MS and other diseases involving immune attacks on the
Read More
11/15/2026
A survey of 24 Israeli MS specialists found agreement on weighing more than age when treating older
Read MoreNot all studies carry the same weight: sample size, study design and whether results were replicated all matter. The credibility score above reflects the journal, and the original paper is linked under More Details. Read how MS Buddy selects and scores research, and talk to your MS care team before acting on any study.
